Literature DB >> 8328458

Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin.

K Matsumura1, I Nonaka, F M Tomé, K Arahata, H Collin, F Leturcq, D Récan, J C Kaplan, M Fardeau, K P Campbell.   

Abstract

The dystrophin-glycoprotein complex spans the sarcolemma to provide a linkage between the subsarcolemmal cytoskeleton and the extracellular matrix in skeletal muscle. In Duchenne muscular dystrophy (DMD), the absence of dystrophin leads to a drastic reduction in all of the dystrophin-associated proteins in the sarcolemma, thus causing the disruption of the dystrophin-glycoprotein complex and the loss of the linkage to the extracellular matrix. The resulting sarcolemmal instability is presumed to render muscle fibers susceptible to necrosis. In the present study, we investigated the status of the dystrophin-associated proteins in the skeletal muscle from patients with Becker muscular dystrophy (BMD), a milder allelic form of DMD. BMD patients having in-frame deletions in the rod domain of dystrophin showed a mild to moderate reduction in all of the dystrophin-associated proteins in the sarcolemma, but this reduction was not as severe as that in DMD patients. The reduction of the immunostaining for the dystrophin-associated proteins showed a good correlation with that for dystrophin in both intensity and distribution. Our results indicate that (1) the abnormality of the sarcolemmal glycoprotein complex, which is similar to but milder than that in DMD patients, also exists in these BMD patients and (2) the rod domain of dystrophin is not crucial for the interaction with the dystrophin-associated proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328458      PMCID: PMC1682334     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.

Authors:  O Ibraghimov-Beskrovnaya; J M Ervasti; C J Leveille; C A Slaughter; S W Sernett; K P Campbell
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

2.  Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin.

Authors:  M Way; B Pope; R A Cross; J Kendrick-Jones; A G Weeds
Journal:  FEBS Lett       Date:  1992-04-27       Impact factor: 4.124

3.  Molecular genetic and immunological analysis of dystrophin of a young patient with X-linked muscular dystrophy.

Authors:  K Ikeya; K Saito; K Hayashi; H Tanaka; Y Hagiwara; M Yoshida; A Yamauchi; Y Fukuyama; T Ishiguro; C Eguchi
Journal:  Am J Med Genet       Date:  1992-06-01

4.  Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy.

Authors:  K Matsumura; I Nonaka; K P Campbell
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

5.  Primary structure of dystrophin-related protein.

Authors:  J M Tinsley; D J Blake; A Roche; U Fairbrother; J Riss; B C Byth; A E Knight; J Kendrick-Jones; G K Suthers; D R Love
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

6.  Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle.

Authors:  K Matsumura; J M Ervasti; K Ohlendieck; S D Kahl; K P Campbell
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

7.  Glycoprotein-binding site of dystrophin is confined to the cysteine-rich domain and the first half of the carboxy-terminal domain.

Authors:  A Suzuki; M Yoshida; H Yamamoto; E Ozawa
Journal:  FEBS Lett       Date:  1992-08-17       Impact factor: 4.124

8.  Dystrophin in frameshift deletion patients with Becker muscular dystrophy.

Authors:  S B Gangopadhyay; T G Sherratt; J Z Heckmatt; V Dubowitz; G Miller; M Shokeir; P N Ray; P N Strong; R G Worton
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

9.  Delayed expression of dystrophin on regenerating muscle from two siblings with Becker muscular dystrophy.

Authors:  N Tachi; S Wakai; Y Watanabe; S Chiba; M Nagaoka; R Minami
Journal:  J Neurol Sci       Date:  1992-07       Impact factor: 3.181

10.  Analysis of the actin-binding domain of alpha-actinin by mutagenesis and demonstration that dystrophin contains a functionally homologous domain.

Authors:  L Hemmings; P A Kuhlman; D R Critchley
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

View more
  4 in total

Review 1.  Increasing complexity of the dystrophin-associated protein complex.

Authors:  J M Tinsley; D J Blake; R A Zuellig; K E Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

2.  Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle.

Authors:  Erik P Rader; Rolf Turk; Tobias Willer; Daniel Beltrán; Kei-Ichiro Inamori; Taylor A Peterson; Jeffrey Engle; Sally Prouty; Kiichiro Matsumura; Fumiaki Saito; Mary E Anderson; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-13       Impact factor: 11.205

3.  Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.

Authors:  A V Winnard; J R Mendell; T W Prior; J Florence; A H Burghes
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

4.  A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart.

Authors:  F Muntoni; L Wilson; G Marrosu; M G Marrosu; C Cianchetti; L Mestroni; A Ganau; V Dubowitz; C Sewry
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.